NASDAQ · Medical - Devices

908 Devices Inc. (MASS) Stock

$11.49 +1.23% NASDAQ: MASS Healthcare

Valuation

MetricValue
Price$11.49
Market Cap$474.92M
P/E Ratio-13.65
P/B Ratio3.78
P/S Ratio8.56
EPS (TTM)$0.54
52-Week High$12.93
52-Week Low$5.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.50%
ROA-17.46%
ROCE-18.90%
Gross Margin-42.86%
Operating Margin-42.86%
Net Margin-56.68%
Debt/Equity0.03
Current Ratio4.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$47.0M$50.0M$60.0M$56.0M
Operating Profit$-22.0M$-35.0M$-43.0M$-77.0M$-24.0M
Net Profit$-22.0M$-34.0M$-36.0M$-72.0M$-37.0M
EPS$-0.79$-1.07$-1.13$-2.12$-0.94
Op Margin-52.3%-75.5%-85.1%-128.7%-43.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$261.0M$243.0M$203.0M$159.0M$190.0M
Total Liabilities$46.0M$52.0M$37.0M$45.0M$46.0M
Cash$224.0M$188.0M$121.0M$44.0M$113.0M
Borrowings$21.0M$20.0M$6.0M$7.0M$17.0M

Latest News

Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031 GlobeNewswire · Jul 6, 2026 908 Devices (MASS) Upgraded to Buy: Here's Why Zacks · Jun 4, 2026 908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire · Jun 2, 2026 908 Devices MASS Q1 2026 Earnings Transcript Motley Fool · May 7, 2026 908 Devices Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-21.0M$-25.0M$-30.0M$-24.0M
Investing Cash Flow$-1.0M$-18.0M$-28.0M$-47.0M$50.0M
Financing Cash Flow$94.0M$0$-2.0M$-2.0M$-2.0M
Net Cash Flow$65.0M$-36.0M$-67.0M$-77.0M$26.0M
Free Cash Flow$-30.0M$-23.0M$-27.0M$-31.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-15.52
FCF Yield0.09%
Quick Ratio2.38
Interest Coverage—
Return 1Y-3.00%
Return 3Y-5.83%
Return 5Y-74.35%

Ownership

Insiders Held8.21%
Institutions Held82.81%
Institutions Float Held90.21%
Institutional HolderSharesReport Date
First Light Asset Management, LLC6,072,5632026-03-31
AWM Investment Company, Inc.5,199,9242026-03-31
ARK Investment Management, LLC1,946,6852026-03-31
Blackrock Inc.1,767,3162026-03-31
Needham Investment Management, L.L.C.1,240,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $173.07 -0.47% 33.95 $48.80B 0.59%
QGENQiagen N.V. $50.39 +0.34% 22.95 $10.38B 1.56%

About 908 Devices Inc.

908 Devices Inc. is led by CEO Kevin J. Knopp, publicly traded since 2020.

908 Devices Inc. (MASS) stock trades at $11.49 with a market capitalization of $474.92M. The stock is valued at a negative price-to-earnings (P/E) ratio of -13.65, reflecting a net loss over the last twelve months, price-to-book of 3.78, price-to-sales of 8.56. Over the past 52 weeks the stock has ranged between $5.03 and $12.93, and currently trades 11.1% below its 52-week high.

On profitability, 908 Devices Inc. generates a return on equity (ROE) of -25.50% (negative, reflecting a net loss), return on capital employed of -18.90%, an operating margin of -42.86%, a net profit margin of -56.68%.

908 Devices Inc. by the numbers, 2018–2025

Between 2018 and 2025 908 Devices Inc. reported revenue of $22.0M rising to $56.0M, a change of +154.5% across 8 years. Compounded, revenue has grown 15.7% a year over five years, 6.0% over three, -6.7% over the last twelve months. Net profit fell to $-37.0M.

Operating margin went from -29.2% in 2018 to -43.0% in 2025, a fall of 13.8 percentage points. The most recent net margin is -56.68%. On a trailing twelve-month basis to Jun '26, revenue is $60.0M and net profit $-35.0M.

Borrowings fell from $18.0M to $17.0M, cash from operations was $-24.0M in the latest year, positive in 1 of the last 8.

Return on equity has averaged -27.6% over five years, and was -25.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

908 Devices Inc. (MASS) — frequently asked questions

What is 908 Devices Inc. (MASS) stock price today?

908 Devices Inc. (MASS) is currently trading at $11.49, up 1.23% today.

What is MASS P/E ratio?

908 Devices Inc.'s P/E ratio is -13.65. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MASS return on equity (ROE)?

908 Devices Inc.'s return on equity (ROE) is -25.50%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is 908 Devices Inc.'s market cap?

908 Devices Inc. has a market capitalization of $474.92M.

Does MASS pay a dividend?

908 Devices Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does MASS carry?

908 Devices Inc. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MASS's profit margin?

908 Devices Inc. reports a net profit margin of -56.68% — the share of revenue left after every cost, including tax and interest.

What sector is MASS in?

908 Devices Inc. is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MASS listed on?

908 Devices Inc. trades on NASDAQ under the ticker MASS.

What is MASS's 52-week range?

Over the last year 908 Devices Inc. has traded between $5.03 and $12.93.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens MASS currently matches

On the figures above, 908 Devices Inc. passes the filters for 7 of our ready-made screens, among them Small Cap Stocks, Debt Free Stocks Under $100, Debt Free Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksDebt Free Stocks Under $100Debt Free StocksStocks Under $100Stocks Under $50Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.